India’s nutraceutical sector is on the verge of a significant transformation, poised to outpace the pharmaceutical industry by a margin of tenfold. This growth potential is primarily driven by the increasing role of health supplements, probiotics, and prebiotics in everyday preventive healthcare. Pritee Chaudhary, the regional director of the Food Safety and Standards Authority of India (FSSAI), emphasized these insights during her address at the fourth edition of Vitafoods India in Mumbai.
Current Market Landscape
At present, the nutraceutical sector accounts for nearly 2% of the global market. Chaudhary highlighted that this figure is expected to rise dramatically as the industry aligns itself with the broader vision of Viksit Bharat 2047, positioning nutraceuticals as a strategic pillar in nation-building efforts. The event, held from February 11 to 13, serves as a unifying platform for stakeholders in India’s nutraceutical, functional food, beverage, and dietary supplement sectors.
Regulatory Framework and Manufacturing Base
India’s robust pharmaceutical expertise, combined with a supportive regulatory framework from FSSAI, lays the groundwork for this anticipated growth. The country is also witnessing an expansion of its manufacturing capabilities, particularly in key regions like Gujarat and Himachal Pradesh. With more than 60 free trade agreements established with important markets such as the UK, EU, USA, and UAE, India is well-positioned to scale its nutraceutical offerings responsibly.
Global Market Projections
Kaushik Desai, Secretary General of the Health Foods and Dietary Supplements Association (HADSA), projected that the global nutraceutical industry could reach USD 919 billion by 2030, with a compound annual growth rate (CAGR) of 7%. As the market expands, collaboration between FSSAI and industry stakeholders becomes crucial to ensure safety, quality, and regulatory compliance. This focus on clinically validated and evidence-based products is key to reinforcing consumer trust.
Leveraging Traditional Medicine
India’s rich biodiversity and heritage of traditional medicine provide a strong foundation for developing competitive nutraceutical products. With a concentrated effort on research, innovation, and compliance, the sector is poised to enhance access to preventive healthcare. Desai underscored the importance of leveraging these assets to drive growth and foster international competitiveness.
The Role of Nutrition in National Health
Yogesh Mudras, managing director of Informa Markets in India, noted that the country is entering a pivotal decade where nutrition will significantly impact health and productivity outcomes. As per capita disposable income rises, consumers are increasingly investing in preventive health and personalized nutrition. This trend is bolstered by national initiatives like the National Nutrition Strategy, which aims to create a robust regulatory ecosystem under FSSAI.
Vision for the Future
The Vitafoods India event serves as a vision platform where science, policy, and innovation coalesce, enabling the nutraceutical sector to transition from intent to impactful action. Mudras highlighted that this collaboration is essential for the industry to evolve from domestic growth to global leadership.
Government Support and Investment
Puunam G Kaushik, deputy managing director at Meteoric Biopharmaceuticals Pvt Ltd., mentioned the Indian government’s allocation of Rs 10,000 crore for the biopharmaceutical industry, set to roll out over five years from 2026 to 2031. This investment represents a significant opportunity for innovation and capacity building within the sector.
Accelerated Growth Post-COVID
The nutraceutical sector is expected to experience substantial growth, particularly in the Asia Pacific region, as the global shift towards preventive healthcare accelerates following the COVID-19 pandemic. Kaushik pointed out that market expansion could see a threefold increase over the next five years, driven by heightened focus on immunity, nutrition, and overall wellness.
Key Takeaways
- India’s nutraceutical sector is projected to exceed pharmaceuticals by tenfold, driven by preventive healthcare products.
-
A supportive regulatory framework and strong manufacturing base are critical for growth.
-
Collaboration between FSSAI and industry players is essential for ensuring product safety and consumer trust.
-
Traditional medicine and biodiversity present unique opportunities for competitive offerings.
-
Increased consumer investment in health and nutrition is reshaping the market landscape.
Conclusion
India’s nutraceutical sector stands at a critical juncture, with vast potential to redefine health outcomes on a national and global scale. By harnessing its unique assets and fostering collaboration, the industry is well-positioned for remarkable growth. With a clear vision and strategic investments, the future of nutraceuticals in India looks incredibly promising.
Read more → www.devdiscourse.com